These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2706427)

  • 1. Cystic fibrosis and drug-induced arthropathy.
    Jawad AS
    Br J Rheumatol; 1989 Apr; 28(2):179-80. PubMed ID: 2706427
    [No Abstract]   [Full Text] [Related]  

  • 2. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.
    Alfaham M; Holt ME; Goodchild MC
    Br Med J (Clin Res Ed); 1987 Sep; 295(6600):699. PubMed ID: 3117310
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin.
    Schaad UB; Stoupis C; Wedgwood J; Tschaeppeler H; Vock P
    Pediatr Infect Dis J; 1991 Oct; 10(10):723-9. PubMed ID: 1945573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.
    Rubio TT
    Diagn Microbiol Infect Dis; 1990; 13(2):153-5. PubMed ID: 2114953
    [No Abstract]   [Full Text] [Related]  

  • 5. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitivity associated with ciprofloxacin use in adult patients with cystic fibrosis.
    Burdge DR; Nakielna EM; Rabin HR
    Antimicrob Agents Chemother; 1995 Mar; 39(3):793. PubMed ID: 7793897
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey.
    Danisovicová A; Brezina M; Belan S; Kayserová H; Kaiserová E; Hruskovic I; Orosová K; Dluholucký S; Galova K; Mathéova E
    Chemotherapy; 1994; 40(3):209-14. PubMed ID: 8205939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.
    Samuelson WM; Pleasants RA; Whitaker MS
    Ann Pharmacother; 1993 Mar; 27(3):302-3. PubMed ID: 8453165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy in two patients with cystic fibrosis treated with ciprofloxacin.
    Moore GC; Redfern J; Shiach CR; Webb K; Jones AM
    J Cyst Fibros; 2007 May; 6(3):209-11. PubMed ID: 17045852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment: Ciprofloxacin excretion into breast milk.
    Fulton B; Moore LL
    DICP; 1990 Nov; 24(11):1122. PubMed ID: 2275247
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of ciprofloxacin in children with cystic fibrosis.
    Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
    Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance and safety of ciprofloxacin in paediatric patients.
    Black A; Redmond AO; Steen HJ; Oborska IT
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():25-9. PubMed ID: 2292542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.
    Schaad UB; Wedgwood J; Ruedeberg A; Kraemer R; Hampel B
    Pediatr Infect Dis J; 1997 Jan; 16(1):106-11; discussion 123-6. PubMed ID: 9002119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis.
    Bald M; Ratjen F; Nikolaizik W; Wingen AM
    Pediatr Infect Dis J; 2001 Mar; 20(3):320-1. PubMed ID: 11303842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
    Rubio TT; Shapiro C
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():147-52. PubMed ID: 3100490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential quinolone-induced cartilage toxicity in children.
    Camp KA; Miyagi SL; Schroeder DJ
    Ann Pharmacother; 1994 Mar; 28(3):336-8. PubMed ID: 8193422
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy and safety of ciprofloxacin and ofloxacin in chronic Pseudomonas aeruginosa infection in cystic fibrosis.
    Jensen T; Pedersen SS; Nielsen CH; Høiby N; Koch C
    J Antimicrob Chemother; 1987 Oct; 20(4):585-94. PubMed ID: 3479420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin therapy in cystic fibrosis.
    Scully BE; Nakatomi M; Ores C; Davidson S; Neu HC
    Am J Med; 1987 Apr; 82(4A):196-201. PubMed ID: 3555036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
    Kesseler A; Lacassie A; Hugot JP; Talon P; Thomas D; Astier L
    Ann Pediatr (Paris); 1989 Apr; 36(4):275-8. PubMed ID: 2742312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.